|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.83 USD | -2.86% |
|
-4.02% | +35.85% |
| 04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
| 04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Avid Bioservices, Inc. provided revenue guidance for fiscal 2023. The company provides revenue guidance for fiscal 2023 of $140 million to $145 million, a 17% - 21% increase over fiscal 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.85% | 577M | |
| -2.12% | 89.22B | |
| +1.32% | 40.49B | |
| -15.73% | 32.79B | |
| +64.13% | 26.23B | |
| -21.28% | 14.52B | |
| -8.50% | 13.09B | |
| -44.07% | 11.6B | |
| -13.06% | 11.5B | |
| +4.94% | 8.82B |
AVID BIOSERVICES, INC. 
